Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: An analysis of outcome and treatment choices in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO I) and Assessment of the Safety of a New Thrombolytic (ASSENT 2) studies

Gabriel I. Barbash, Yochai Birnbaum, Kris Bogaerts, Michael Hudson, Emmanuel Lesaffre, Yuling Fu, Shaun Goodman, Katrijn Houbracken, Kurt Munsters, Chris B. Granger, Karen Pieper, Robert M. Califf, Eric J. Topol, Frans Van de Werf

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: An analysis of outcome and treatment choices in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO I) and Assessment of the Safety of a New Thrombolytic (ASSENT 2) studies'. Together they form a unique fingerprint.

Medicine & Life Sciences